Dr. Piraye Yurttas Beim

Founder and CEO of Celmatix, Genomics Pioneer in Women’s Health

Dr. Beim has been innovating in women's health for over two decades. During her doctoral work at Cornell and Memorial Sloan Kettering, she saw firsthand how precision medicine and genomics transformed oncology and improved the standard of care. Following a post-doc at the University of Cambridge focused on mammalian reproduction, she founded Celmatix to bring that same level of innovation to women’s health.
Under her leadership, Celmatix pioneered the decoding of the genomic drivers of ovarian function through an ambitious, decade-long multi-omics initiative. A primary inventor of most of Celmatix’s breakthroughs, including novel AMHR2 modulators, she has also developed diagnostics and digital health products. Widely recognized as a business leader, Dr. Beim has been honored by the Aspen Global Leadership Network, Fortune, Goldman Sachs, and Rock Health for her disruptive influence in the industry.